Lokelma OverviewSodium zirconium cyclosilicate (ZS-9) is a selective oral sorbent that traps potassium ions throughout the gastrointestinal tract. It is being developed by ZS Pharma and AstraZeneca for the treatment of hyperkalemia (elevated serum potassium levels). Contents 1 Background 2 Mechanism of action 3 Clinical studies 4 Regulatory 5 See also 6 References Background Main article: Hyperkalemia Hyperkalemia occurs in 3 to 10% of hospitalized patients but ...
Read more Lokelma Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sodium_zirconium_cyclosilicate
Recent Lokelma Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
Sodium Zirconium Cyclosilicate
- For Suspension: 10gm/packet, 5gm/packet
NDC Database Records for Lokelma: (2 results)Sorted by National Drug Code
- 0310-1105 Lokelma 5 g/5g Oral Powder, for Suspension by Astrazeneca Pharmaceuticals Lp
- 0310-1110 Lokelma 10 g/10g Oral Powder, for Suspension by Astrazeneca Pharmaceuticals Lp